SCHEMBL2572427

SCHEMBL2572427

CCC(CC)COc1ccc(-c2ccc(-c3ccc(-c4ccc(OCC(CC)CC)cc4)s3)s2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 8/20 0.48
▸ MAPT P10636 2/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ CYP1A2 P05177 2/20 0.39
▸ CYP3A4 P08684 2/20 0.39
▸ CYP2D6 P10635 2/20 0.39
▸ CYP1A1 P04798 1/20 0.39
▸ CYP2E1 P05181 1/20 0.39
▸ CYP2C8 P10632 1/20 0.39
▸ CYP2A6 P11509 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP4B1 P13584 1/20 0.39
▸ CYP2B6 P20813 1/20 0.39
▸ CYP3A5 P20815 1/20 0.39
▸ CYP2A7 P20853 1/20 0.39
▸ CYP3A7 P24462 1/20 0.39
▸ CYP2F1 P24903 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2566987 0.88 CYP3A4 (0.41) APPMAPTNPC1ALDH1A1RAB9A
SCHEMBL18418540 0.83 APP (0.37) APPMAPTNPC1ALDH1A1RAB9A
SCHEMBL17835291 0.81 APP (0.36) APPMAPTNPC1ALDH1A1RAB9A
SCHEMBL15786690 0.80 CYP3A4 (0.41) APPMAPTNPC1ALDH1A1RAB9A
SCHEMBL13464244 0.80 NQO1 (0.58) APPMAPTNPC1ALDH1A1RAB9A
SCHEMBL22298999 0.79 NR1H4 (0.38) APPMAPTNPC1ALDH1A1RAB9A
SCHEMBL22299739 0.79 MAPT (0.36) APPMAPTNPC1ALDH1A1RAB9A
SCHEMBL27961979 0.77 NQO1 (0.61) APPMAPTNPC1ALDH1A1RAB9A
SCHEMBL21387865 0.77 RAB9A (0.40) APPMAPTNPC1ALDH1A1RAB9A
SCHEMBL4005060 0.77 APP (0.46) APPMAPTNPC1ALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1943239-B1 PHENYLENE-THIOPHENE OLIGOMERS AS ORGANIC SEMICONDUCTORS BASF SE (DE) 2011-11-09 — — EP claimed
US-7569415-B2 Liquid phase fabrication of active devices including organic semiconductors ALCATEL-LUCENT USA INC. (US) 2009-08-04 — — US claimed
US-7488834-B2 Organic semiconductors ALCATEL-LUCENT USA INC. (US) 2009-02-10 — — US claimed
EP-1943239-A1 PHENYLENE-THIOPHENE OLIGOMERS AS ORGANIC SEMICONDUCTORS BASF SE (DE) 2008-07-16 — — EP claimed
EP-1943688-A1 LIQUID PHASE FABRICATION OF ACTIVE DEVICES INCLUDING ORGANIC SEMICONDUCTORS BASF SE (DE) 2008-07-16 — — EP claimed
EP-1943690-A1 ORGANIC COMPOSITIONS BASF SE (DE) 2008-07-16 — — EP claimed
WO-2007039575-A1 LIQUID PHASE FABRICATION OF ACTIVE DEVICES INCLUDING ORGANIC SEMICONDUCTORS BASF SE (DE) 2007-04-12 — — WO claimed
WO-2007039547-A1 ORGANIC COMPOSITIONS BASF SE (DE) 2007-04-12 — — WO claimed
WO-2007039574-A1 PHENYLENE-THIOPHENE OLIGOMERS AS ORGANIC SEMICONDUCTORS BASF SE (DE) 2007-04-12 — — WO claimed
US-20070078267-A1 Organic semiconductors ALCATEL-LUCENT USA INC. 2007-04-05 — — US claimed
US-20070077681-A1 Liquid phase fabrication of active devices including organic semiconductors ALCATEL-LUCENT USA INC. 2007-04-05 — — US claimed
US-20070075630-A1 Organic compositions BASF AKTIENGESELLSCHAFT (DE) 2007-04-05 — — US claimed
EP-1943239-B1 PHENYLENE-THIOPHENE OLIGOMERS AS ORGANIC SEMICONDUCTORS BASF SE (DE) 2011-11-09 — — EP disclosed
US-7569415-B2 Liquid phase fabrication of active devices including organic semiconductors ALCATEL-LUCENT USA INC. (US) 2009-08-04 — — US disclosed
US-7569415-B2 Liquid phase fabrication of active devices including organic semiconductors ALCATEL-LUCENT USA INC. (US) 2009-08-04 — — US disclosed
US-7488834-B2 Organic semiconductors ALCATEL-LUCENT USA INC. (US) 2009-02-10 — — US disclosed
US-20070078267-A1 Organic semiconductors ALCATEL-LUCENT USA INC. 2007-04-05 — — US disclosed
US-20070078267-A1 Organic semiconductors ALCATEL-LUCENT USA INC. 2007-04-05 — — US disclosed
US-20070077681-A1 Liquid phase fabrication of active devices including organic semiconductors ALCATEL-LUCENT USA INC. 2007-04-05 — — US disclosed
US-20070077681-A1 Liquid phase fabrication of active devices including organic semiconductors ALCATEL-LUCENT USA INC. 2007-04-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070078267-A1 Organic semiconductors ORC3, C1S, C5 APP 3087/4885MAPT 1560/4885NPC1 4240/4885
US-20070075630-A1 Organic compositions BPNT1, RFT1, FERMT2 APP 1318/4885MAPT 17/4885NPC1 3860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback